REPHENIDATE LA 20 MG MODIFIED-RELEASE CAPSULES

Страна: Ізраїль

мова: англійська

Джерело: Ministry of Health

Активний інгредієнт:

METHYLPHENIDATE HYDROCHLORIDE

Доступна з:

DEXCEL LTD, ISRAEL

Код атс:

N06BA04

Фармацевтична форма:

MODIFIED RELEASE CAPSULES

Склад:

METHYLPHENIDATE HYDROCHLORIDE 20 MG

Адміністрація маршрут:

PER OS

Тип рецепту:

Required

Виробник:

LABORATORIOS RUBIÓ, S.A. , SPAIN

Терапевтична области:

METHYLPHENIDATE

Терапевтичні свідчення:

Attention deficit hyperactivity disorder (ADHD)

Дата Авторизація:

2022-09-11

інформаційний буклет

REPHENIDATE
® LA
10, 20, 30, 40, 60
MG
MODIFIED-RELEASE CAPSULES
Each capsule contains Methylphenidate hydrochloride
10, 20, 30, 40 or 60 mg respectively.
Inactive ingredients and allergens in the medicine –
see section 6 "Additional information" and in section 2
"Important information about some of the ingredients of
the medicine”.
READ THIS ENTIRE LEAFLET CAREFULLY BEFORE USING THE
MEDICINE.
This
leaflet
contains
concise
information
about the medicine. If you have any further questions,
ask the doctor or pharmacist.
This medicine has been prescribed for you. Do not pass
it on to others. It may harm them, even if you think that
their medical condition is the same as yours.
1. WHAT IS THE MEDICINE INTENDED FOR?
For treatment of Attention Deficit Hyperactivity Disorder
(ADHD).
THERAPEUTIC GROUP: Central nervous system stimulant.
REPHENIDATE LA capsules contain the active ingredient
methylphenidate hydrochloride. Methylphenidate
hydrochloride is a central nervous system stimulant.
REPHENIDATE LA capsules are used to treat Attention
Deficit
Hyperactivity
Disorder
(ADHD
or
hyperkinetic
disorder) which is a behavioral disorder in children,
adolescents, and adults. About 3% of children suffer
from this disorder, which makes them unable to sit still or
concentrate on tasks for any length of time. Children with
this disorder may have difficulty in learning and doing
homework.
It may frequently be difficult to manage them both in
school and at home.
Adults with ADHD often find it hard to concentrate. They
often feel restless, impatient, inattentive and become
bored easily. They may experience difficulty organizing
their private life and work.
Methylphenidate
is
assumed
to
work
by
regulating
specific chemicals in the brain that affect behavior. It
helps focus attention, shuts out distraction and allows
impulsive people to think before they act. If treatment is
successful, it improves the person's natural ability to be
attentive.
This medicine is part of a treatment program which
usually
also
includes
psychological,
ed